Context: Telomeres protect chromosomes from damage, and shorter leucocyte telomere length (LTL) is a marker of advancing biological age. The association between testosterone (T) and its bioactive metabolites, dihydrotestosterone (DHT) and oestradiol (E2) with telomere length, particularly in older men, is uncertain. The study aimed to clarify associations of sex hormones with LTL in older men.
| INTRODUC TI ON
Telomeres are essential DNA-protein complexes comprising TTAGGG repeats binding specific proteins, which protect the physical ends of chromosomes from fusion and degradation.
1 Conventional DNA replicative enzymes cannot fully replicate the DNA sequence at telomere ends, thus their length progressively shortens with each cell cycle. 2 Attrition of telomeres results in cellular senescence, characterized by alterations in gene expression, cell cycle arrest and ultimately loss of viability when telomere length declines to a critical value. [1] [2] [3] Measurement of telomere length can be performed in DNA extracted from leucocytes and the results correlate with telomere length measured in various tissues. 4, 5 Consistent with the relationship between ageing and shorter telomere length, age-related declines in leucocyte telomere length (LTL) are found in both men and women. 6 Furthermore, shorter LTL predicts higher risk of ill-health characteristic of advancing age, including incidence of myocardial infarction, stroke, type 2 diabetes and to some extent mortality.
7,8
Factors such as obesity and smoking are associated with telomere shortening, while tobacco abstinence and physical activity or fitness are associated with longer telomeres. [9] [10] [11] Telomere homeostasis is a dynamic process with telomere shortening countered by the activity of telomerase, the enzyme responsible for elongating telomeres by addition of telomeric repeats. 1 Thus telomere length is a biomarker for and putative mediator of biological ageing, and factors which predict increased telomere length offer potential avenues for interventions to preserve health.
Men tend to have shorter LTL than women of comparable age, raising the possibility of sex hormone exposure contributing to the regulation of telomere length. 6 In men, circulating testosterone (T) declines and vulnerability to multiple comorbidities increases with advancing age. 12 In experimental studies using various cell lines, both testosterone (T) and its bioactive metabolite oestradiol (E2) increased telomerase expression and/or activity. [13] [14] [15] [16] [17] Thus regulation of telomere length may be a mechanism by which reduced sex hormone exposure might accelerate biological ageing. However, there are few studies examining the association of sex hormones with LTL in men and those reported have contrasting results. In one study of 110 older men, neither T nor E2 measured using immunoassay was associated with LTL. 18 By contrast, an analysis of 980 predominantly middle-aged men from the Busselton Health Study found that circulating concentrations of both bioactive metabolites of T, dihydrotestosterone (DHT) and E2, assayed using mass spectrometry, correlated with LTL. 19 However a recent analysis of 499 adult men from the National Health and Nutrition Examination Survey (NHANES) was contradictory, reporting an inverse association of circulating E2 measured using immunoassay with LTL. 20 A larger and more comprehensive analysis involving older men and using mass spectrometry for analysis of sex hormones would address this question.
We aimed to assess whether circulating concentrations of T, DHT and E2, and their principal carrier protein sex hormone-binding globulin (SHBG), were associated with LTL in community-dwelling older men in relatively good health, independently of age and cardiometabolic risk factors.
| PARTI CIPANTS AND ME THODS

| Study population
The Health In Men Study (HIMS) is a population-based cohort study of community-dwelling older men from Perth, Western Australia. 
| Definition of medical comorbidities and physical activity levels
Blood pressure, height and weight recorded at W2 were analysed.
Body mass index (BMI) was defined as weight (kg) divided by height (m) squared. A history of cardiovascular disease (CVD) was defined as any self-reported history of heart attack or stroke, heart bypass surgery or balloon angioplasty, aortic aneurysm or surgery to the aorta, carotid or lower limb arteries at W2. Use of hypertensive medications was recorded from questionnaire responses at W2. Men diagnosed with diabetes, reporting use of glucose-lowering medication, or with fasting or nonfasting glucose at W2 of ≥7 mmol/L or ≥11.1 mmol/L, respectively, were considered to have diabetes. Physical activity was assessed using questionnaire in W1. Physical activity was the sum of the number of hours in a usual week of nonvigorous and 2x the number of hours of vigorous physical activities, reflecting the higher exercise intensities associated with vigorous activities.
| Laboratory assays for circulating sex hormones
Blood samples were collected between 08:00 and 10:30 hours at W2.
Plasma and serum aliquots were prepared immediately after phlebotomy and stored at −80°C until assayed. Plasma total T, DHT and E2
concentrations were quantified using liquid chromatography-tandem mass spectrometry (LC-MS/MS) as reported previously. and controls were run in triplicate, and the median value used for analyses. A standard curve derived from K562 cell line was used to transform the cycle threshold into nanograms of DNA. The amount of telomeric DNA (T) was divided by the amount of single-copy control gene DNA (S), producing a relative measurement of the telomere length (T/S ratio).
The coefficient of variation for the quantitative PCR across all batches was <10%. As some men did not provide a leucocyte DNA sample at W2 (choosing to provide blood samples only for plasma and serum), DNA for analysis of LTL were available for 3894 men.
| Statistical analysis
SAS version 9.4 was used (SAS Institute, Cary, NC, USA). Characteristics of the study population are presented as mean ± standard deviation (SD) for continuous data, and n (%) for categorical data. 
| RE SULTS
| Characteristics of the study population
After excluding men taking androgen-related medications or with history of orchidectomy or prostate cancer there were 3532 men.
However, some men had missing data on hormones, LTL or key covariates and after excluding these there were 3018 communitydwelling men for inclusion in the initial analysis. Characteristics of these 3018 men and the 514 men excluded due to missing key data are shown (Table 1 ). In total, 34% had a history of CVD and 14.0% diabetes. Excluded men had a similar history and cardiovascular profile to the study population. Of the study population, 2913 were aged 70-84 years and 105 were aged 85-89 years.
| Associations of age with sex hormones and LTL
The relationships of age to sex hormones, SHBG and LTL are shown (Table 2) . T, cFT, DHT and E2 showed consistent declines with age, while SHBG increased with age. T/S ratio showed a decline with age from 70-74, 75-79 and 80-84 years. Of note, there were only 105 men in the age stratum 85-89 years, and these men showed stable sex hormone and SHBG concentrations and higher T/S ratios compared to men aged 80-84 years (Table 2 ). This phenomenon, consistent with a healthy survivor effect, has been observed in previous epidemiological studies. 6 Therefore, as these men aged 
| Multivariate analyses of hormones and LTL
Linear regressions of T/S ratio on hormones after adjustment for age, cardiometabolic risk factors and CVD history are shown (Table 3 ).
E2 showed a significant multivariable adjusted association with LTL (Table 3 ). The estimated difference in T/S ratio was 0.011 per 1 SD increase in E2. T, cFT, DHT and SHBG were not associated with LTL.
Results for cFT mirrored those for T and did not provide any additional information.
29
The association of T with LTL remained nonsignificant when included in a model that also included SHBG. The model with both E2 and SHBG showed significant associations for E2 and SHBG (inversely) with LTL ( Table 3) . The full fitted model including both E2 and SHBG is shown (Table 4) . Age, BMI, HDL and SHBG were inversely associated with LTL, while total cholesterol and E2 were positively associated in the full fitted model. The effect size expressed as difference in T/S ratio was comparable for E2 with these other covariates ( Table 4 ). The increase in T/S ratio associated with a 1 SD higher plasma E2 concentration was comparable in magnitude to the decrease associated with having a BMI 3.6 kg/m 2 higher and was two-thirds the decrease associated with being 3.6 years older.
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| D ISCUSS I ON
In this analysis of 2913 community-dwelling men aged 70-84 years, T, DHT and E2 concentrations declined with age, with a parallel decline in LTL expressed as the T/S ratio. Plasma E2 concentrations were independently associated with longer LTL, while SHBG concentrations were inversely associated. T and DHT were not associated with LTL in older men. The correlations were modest with correlation coefficients of 0.038 for E2 and −0.053 for SHBG with T/S ratio, respectively. These were largely unchanged in the trimmed analyses excluding the highest and lowest 1% of values, thus were not influenced by extreme outliers. In the multivariable model, E2 remained positively and SHBG inversely associated with LTL indicating that the associations are independent of age, BMI and cardiometabolic risk factors. Of note, the magnitude of increase in T/S ratio associated with a 1 SD higher plasma E2 concentration was comparable with having a BMI 3.6 kg/m 2 lower and two-thirds that associated with being 3.6 years younger. Therefore, these findings in an epidemiological study illuminate an association of sex hormones with biological age in older men (see Figure 1) . However, the predictive value of E2, SHBG and LTL in any individual older man is unproven and likely to be limited in view of the moderate associations and large inter-individual variations observed in these parameters.
These findings are in contrast to previous reports (see Table 5 Immunoassays for sex steroids such as T and E2 can suffer from nonspecificity and method-dependent bias, and mass spectrometry is considered more accurate especially at low sex steroid concentrations. [30] [31] [32] Conversely, in 980 men from the Busselton Health Study with mean age 53.7 years where circulating T, DHT and E2 were assayed using mass spectrometry and LTL measured using PCR, 19 both DHT and E2 cor- The full fitted model for study sample (n = 2913) is given in Table 4 . Of note, in the current analysis we did not observe any association of either T or DHT with LTL. As expected, circulating DHT in our study population of older men was lower than in the predominantly middle-aged men from the Busselton analysis (mean DHT 1.42 nmol/L vs 1.77 nmol/L) and telomere length was shorter (mean T/S ratio 1.18 vs 1.69). 19 It is possible that the association of DHT with LTL is less apparent in older men who have shorter telomeres. However, the association of E2 with longer telomeres remains consistent in older men.
The inverse association of SHBG with telomere length is of interest and is independent of E2. A similar scenario is seen with E2, SHBG and bone strength such that lower circulating E2 and higher SHBG concentrations are independently associated with fracture risk in men. 33 Therefore it seems feasible that E2 and SHBG should be reciprocally associated with LTL, with both modulating the effect of hormonal exposure on a specific outcome in a distinct fashion.
As this is a cross-sectional analysis from an observational study, causality cannot be determined. Nevertheless several lines of evidence support a role for E2 to regulate telomerase activity and thereby telomere length. An oestrogen-response element is present in the promoter of the catalytic subunit of the telomerase enzyme; thus, E2 acting transcriptionally could stimulate telomerase activity. 34 Indeed, E2 increased telomerase activity and/or expression in several cell lines in vitro. 13, [15] [16] [17] In an animal model, aromatase knockout mice who are E2 deficient have reduced ovarian telomerase expression and telomere length, which are reversed by E2 therapy. 35 Also, while telomerase activity is repressed in many somatic tissues during extra-uterine life, it is present in highly proliferative tissues including the haematopoietic system, gastrointestinal tract and skin, 36 providing a pathway by which telomerase induction by exposure to sex hormones could result in greater circulating LTL and tissue telomere length. Thus there are recognized mechanisms by which E2 could regulate telomere length. Our findings are consistent with a role for circulating E2 to modulate telomere length in older men, raising the prospect that this bioactive metabolite of T may influence biological ageing in vivo.
Exogenous T undergoes aromatization to E2 in a manner similar to the endogenous hormone. 37 However, it is unclear whether T treatment either in itself, or via provision of substrate for aromatization to E2, would influence telomere length. In a Phase I/II study which enrolled 27 patients with a rare aplastic anaemia associated with short LTL, treatment with the androgenic anabolic steroid danazol slowed attrition of LTL over a period of 24 months in the first 12 patients, leading to the study being halted early. 38 However, the implications of this finding in patients with a defined haematological disease to the broader population of men in the community are unclear. In a study of 40 men commencing androgen deprivation therapy (ADT) for prostate cancer, there was no change in LTL over 24 months when compared to 25 radiotherapy-matched controls. 39 However, the sample sizes were small, and dropouts occurred such that at 12 months there were 28 ADT-treated men and 22 radiotherapy-matched controls, and at 24 months, there were 7 and 12 respectively. 39 Additional studies and ultimately randomized 
| CON CLUS IONS
E2 is independently associated with LTL while SHBG is inversely associated, suggesting that sex hormone exposure is associated with lower biological age in older men. However, causality cannot be inferred from an observational, cross-sectional study; thus, further research is needed to explore whether interventions that modulate sex hormone exposure might preserve telomere length in men. 
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